Klotho Neurosciences, Inc. financial data

Symbol
KLTO, KLTOW on Nasdaq
Location
Omaha, NE
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 459% % 2288%
Debt-to-equity 18% % -99%
Return On Equity -202% % 90%
Return On Assets -171% % -180%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72,536,722 shares 321%
Common Stock, Shares, Outstanding 70,334,792 shares 254%
Entity Public Float $13,600,000 USD -76%
Common Stock, Value, Issued $7,033 USD 254%
Weighted Average Number of Shares Outstanding, Basic 59,416,539 shares 256%
Weighted Average Number of Shares Outstanding, Diluted 59,416,539 shares 256%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $509,845 USD
General and Administrative Expense $991,290 USD 344%
Operating Income (Loss) $6,934,776 USD -79%
Nonoperating Income (Expense) $4,355,285 USD -1078%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $11,290,061 USD -96%
Income Tax Expense (Benefit) $483,868 USD -81%
Net Income (Loss) Attributable to Parent $11,290,061 USD -168%
Earnings Per Share, Basic 0 USD/shares 72%
Earnings Per Share, Diluted 0 USD/shares 72%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,300,000 USD 14243%
Assets, Current $7,773,590 USD 4927%
Intangible Assets, Net (Excluding Goodwill) $2,309,554 USD
Other Assets, Noncurrent $2,309,554 USD
Assets $10,073,144 USD 309%
Accounts Payable, Current $34,905 USD -87%
Accrued Liabilities, Current $57,986 USD -90%
Liabilities, Current $92,891 USD -91%
Deferred Income Tax Liabilities, Net $18,087 USD
Liabilities $145,891 USD -85%
Retained Earnings (Accumulated Deficit) $19,785,597 USD -133%
Stockholders' Equity Attributable to Parent $9,927,253 USD 580%
Liabilities and Equity $10,073,144 USD 309%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,553,747 USD -6970%
Net Cash Provided by (Used in) Financing Activities $2,055,875 USD 1075%
Net Cash Provided by (Used in) Investing Activities $123,496 USD 66%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 70,334,792 shares 254%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,348,034 USD 14338%
Deferred Tax Assets, Valuation Allowance $3,020,853 USD 175%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross $3,020,853 USD 175%
Deferred Tax Assets, Operating Loss Carryforwards $2,389,968 USD 118%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000,000 shares 0%
Additional Paid in Capital $29,705,817 USD 208%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $1,906,237 USD -67%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%